
India’s HIV Prevention Boost: Dr. Reddy’s, Hetero to Supply Gilead’s Lenacapavir at ₹3,500 for Twice-Yearly Dose
Lenacapavir, a highly effective twice-yearly injectable, will greatly increase HIV prevention accessibility in vulnerable populations worldwide.








